Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma, Renal Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07227415
What this trial is testing

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

Who this might be right for
Carcinoma, Renal CellAdvanced Renal Cell CarcinomaRenal Cancer+10 more
Pfizer 224
Not applicableLooking for participantsNCT03702309
What this trial is testing

Liquid Biopsy Evaluation and Repository Development at Princess Margaret

Who this might be right for
CancerBreast CancerLung Cancer+15 more
University Health Network, Toronto 2,500
Testing effectiveness (Phase 2)Ended earlyNCT01762033
What this trial is testing

ASONEP™ to Treat Unresectable and Refractory Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Lpath, Inc. 40
Early research (Phase 1)Looking for participantsNCT07564232
What this trial is testing

Phase 1 Study Of LNK001 In Advanced Or Metastatic Clear Cell Renal Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell Carcinoma
M.D. Anderson Cancer Center 40
Early research (Phase 1)Study completedNCT02903914
What this trial is testing

Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors

Who this might be right for
Metastatic CancerSolid TumorsColorectal Cancer (CRC)+7 more
Incyte Corporation 260
Testing effectiveness (Phase 2)UnknownNCT00226798
What this trial is testing

Immunochemotherapy for Metastatic Renal Cell Carcinoma

Who this might be right for
Adenocarcinoma Clear Cell
Rambam Health Care Campus 45
Early research (Phase 1)Ended earlyNCT04301011
What this trial is testing

Study of TBio-6517 Given Alone or in Combination With Pembrolizumab in Solid Tumors

Who this might be right for
Solid TumorMicrosatellite Stable Colorectal CancerHPV Positive Oropharyngeal Squamous Cell Carcinoma+6 more
Turnstone Biologics, Corp. 27
Testing effectiveness (Phase 2)Active Not RecruitingNCT05879822
What this trial is testing

Evaluate INCB099280 in Participants With Select Solid Tumors Who Are Immune Checkpoint Inhibitor Naive

Who this might be right for
Advanced Solid Tumor
Incyte Corporation 73
Testing effectiveness (Phase 2)Temporarily pausedNCT03575611
What this trial is testing

Stereotactic Body Radiation Therapy in Treating Patients With Oligometastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell CarcinomaStage IV Renal Cell Cancer AJCC v8
M.D. Anderson Cancer Center 123
Not applicableLooking for participantsNCT05810571
What this trial is testing

Comparison of Postoperative Analgesic Efficacy of the Erector Spina Plane Block and Quadratus Lumborum Block in Open Nephrectomy: a Prospective Randomized Clinical Study

Who this might be right for
Renal Cell Carcinoma
Kocaeli University 60
Not applicableLooking for participantsNCT05589207
What this trial is testing

Predicting Model Based on Evidence-based Pathological Diagnose Criteria for RCC Tumor Thrombus With IVC Wall Invasion

Who this might be right for
Carcinoma, Renal CellTumor ThrombusNeoplasm Invasiveness+1 more
Peking University Third Hospital 232
Not applicableLooking for participantsNCT07234409
What this trial is testing

Clinical Trial Addressing the Best Surgical Approach for Partial Nephrectomy With Single Port Robotic System in the Management of Localized Renal Cell Carcinoma

Who this might be right for
Kidney Neoplasm
Niguarda Hospital 124
Not applicableNot Yet RecruitingNCT06773377
What this trial is testing

Study of the Prognostic Impact of CD44 on Renal Cell Carcinoma

Who this might be right for
Renal Cell Cancer
Assiut University 77
Not applicableActive Not RecruitingNCT06954571
What this trial is testing

Imaging-Guided Classification for Endophytic Renal Tumors: PN Strategies & Outcomes

Who this might be right for
Renal Tumors
Tianjin Medical University Second Hospital 190
Not applicableLooking for participantsNCT06676527
What this trial is testing

Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma

Who this might be right for
NeoplasmsKidney NeoplasmsUrologic Neoplasms+10 more
Jinling Hospital, China 39
Not applicableStudy completedNCT00849186
What this trial is testing

Sunitinib and Surgery in Treating Patients With Localized or Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Roswell Park Cancer Institute 20
Testing effectiveness (Phase 2)Study completedNCT00011973
What this trial is testing

Chemotherapy in Treating Patients With Advanced Kidney Cancer

Who this might be right for
Kidney Cancer
Barbara Ann Karmanos Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT00445523
What this trial is testing

Safety Study of TroVax Alone vs. TroVax Plus Interferon Alpha in Patients With Renal Cancer

Who this might be right for
Carcinoma, Renal Cell
The Methodist Hospital Research Institute 28
Testing effectiveness (Phase 2)Study completedNCT01024920
What this trial is testing

Compare Safety and Efficacy of BIBF 1120 Versus Sunitinib.

Who this might be right for
Carcinoma, Renal Cell
Boehringer Ingelheim 99
Large-scale testing (Phase 3)Study completedNCT04987203
What this trial is testing

Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
AVEO Pharmaceuticals, Inc. 343
Next Page